JFG
UTHR icon

Jefferies Financial Group’s United Therapeutics UTHR Stock Holding History

Jefferies Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$2.3M – 1888
2024
Q1 		$2.3M Buy
+10,000
New +$2.26M 0.02% 543

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Jefferies Financial Group's UTHR Position: Q2 2026 in Review

Jefferies Financial Group increased its United Therapeutics (UTHR) stake by 12% in Q2 2026, buying an estimated $392K and bringing the position to 6,697 shares worth $3.63M. The position accounts for 0.02% of the portfolio, ranked #475.

Jefferies Financial Group first reported a position in UTHR in Q1 2023 and has held it in 7 quarters since. The position peaked at $4.46M in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Jefferies Financial Group held 6,697 shares of United Therapeutics worth $3.63M as of Q2 2026.
  • Jefferies Financial Group bought 696 United Therapeutics shares in Q2 2026, an estimated $392K.
  • United Therapeutics made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #475 holding.
  • Jefferies Financial Group first reported a position in United Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • Jefferies Financial Group's United Therapeutics position peaked at $4.46M in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.